Essential Hypertension: An International Symposium. Berne, June 7th–10th, 1960 Sponsored by CIBA

The mosaic theory of hypertension.- Inheritance of high blood pressure.- The nature of essential hypertension.- Discussion.- Possible role of salt intake in the development of essential hypertension.- Renal hemodynamics, water and electrolyte excretion in essential hypertension.- Discussion.- Adrenocortical function and renal pressor mechanisms in experimental hypertension.- Possible relationship between salt metabolism and the angiotensin system.- Discussion.- Adrenocortical function in essential hypertension.- The significance of hyperaldosteronuria in hypertension.- Discussion.- Therapeutic aspects of salt restriction.- Mechanism of hypotensive action of saluretics.- Discussion.- The natural history of benign hypertension.- The natural course of malignant hypertension.- Discussion.- Pharmacology of new hypotensive drugs.- Bretylium and guanethidine (clinical results).- Combined drug therapy of hypertension.- Effects of the administration of saluretic drugs in the treatment of arterial hypertension.- Discussion.- Survival rates in severe hypertension intensively treated with hydralazine and ganglionic blockade.- The late effects of hypotensive drug therapy on renal functions of patients with essential hypertension.- Late results of surgical therapy (sympathectomy and adrenalectomy).- Discussion.- Hypertension and its associated vascular diseases.- Prevention and treatment of “atheromatous complications” of hypertension.- Discussion.- Closing remarks.- List of authors.